Table 26: Impact of eTools on Appropriately Prescribed ACE Inhibitors.
| Author, Year | Study Design | Length of Follow-up | Sample Size, n (Intervention/Control) | Results (Intervention/Control) | Effect Estimate (95% CI) |
|---|---|---|---|---|---|
| Henderson et al, 2010 (36) | Observational | 16 months | 5,838/1,075 encounters | 5.9/4.5 per 100 encounters | aRCa 0.16 (NR) P = 0.86 |
| Walsh et al, 2012 (41) | Observational | 24 months | 4,220/2,950 | ACE inhibitor/ARB improvement in use of therapy from baseline 7.3%/8.6% | aORb 0.83 (0.63–1.09) |
Abbreviations: ACE inhibitor, angiotensin-converting enzyme inhibitor; aOR, adjusted odds ratio; ARB, angiotensin receptor blocker; aRC, adjusted regression correlation; CI, confidence interval; eTool, electronic tool; FRACGP, Fellowship of the Royal Australian College of General Practitioners; GP, general practitioner; NR, not reported.
a
Adjusted for GP age, GP sex, FRACGP status, work in deputizing services in preceding month, bulk billing for all patients, practice accreditation status, presence of a practice nurse.
b
Adjusted for patient and practice characteristics.